Progressive pseudorheumatoid dysplasia (PPD) (MIM 208230), initially described by Wynne-Davies[1] in 1982, is a rare genetic disease triggered by recessive gene mutations in WISP3 (Wnt1-inducible signaling pathway protein 3; MIM 603400). Here, CCN6 is linked to progressive pseudorheumatoid arthropathy of childhood.